Verdacom Launches VerdaCore, a New Web-Based Integrated Platform
Verdacom
introduces its first product, VerdaCore, a new subject randomization and drug supply management system built to service pharmaceutical and biotechnology clinical trials.
VerdaCore is built as a compliant, scalable and flexible platform for collecting and presenting clinical trial data.
"VerdaCore utilizes cloud computing and the power of agile software development to meet the fluid and time critical requirements of today’s increasingly complex clinical trials," said Daniel Scanlon, President of Verdacom. "VerdaCore is built for delivering secure, complex software solutions while meeting the compliance requirements of the pharmaceutical industry.”
VerdaCore is equipped with a number of features to service clinical trials of any size and complexity. Centralized subject randomization and drug supply inventory control provide the core components of the system. Role-based security controls the level of access to data, transactions and application tools. A centralized study contacts component maintains contact information online and is accessible by study team members, investigational sites and all vendors involved with the clinical trial. A shared calendar component details subject and inventory transactions in various calendar views and provides a way to view the progress of the trial. VerdaCore relies on graphical dashboards as a rich front-end for users, and dashboards show the most meaningful information for the trial.
VerdaCore is customized for each clinical trial using an internal end-to-end project quality management system, VerdaTrak. “VerdaTrak's primary focus is internal automated process management and tracking,” said Scanlon.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
